Anaconda Biomed
Anaconda Biomed is a Spanish medical device company developing funnel catheter technology for stroke treatment.
Anaconda Biomed is a Spanish medical device company developing funnel catheter technology for stroke treatment.
The ANA funnel platform is a family of single-use neurovascular catheters built on a self-expanding, radiopaque nitinol funnel covered by a continuous silicone coating. When deployed at the clot interface, the funnel provides high-efficiency aspiration, controlled local flow restriction, and a large receptacle for clot collection, and is intended to be used with interventional devices during stroke thrombectomy.
The lead offering, the ANA5 Funnel Catheter, is indicated for introducing interventional devices into the neurovasculature when restoring blood flow in acute ischemic stroke due to large vessel occlusion. It is CE marked for Europe and remains an investigational device in the United States, where the company's portfolio also spans additional funnel catheter sizes and a companion stent retriever.
Stroke is one of the largest causes of death and long-term disability worldwide, and most of these events are ischemic. Mechanical thrombectomy is the standard of care for large vessel occlusion stroke, yet the number of procedures performed globally each year remains a fraction of the eligible patient population, leaving substantial room for devices that raise first-pass reperfusion rates.
The company is addressing this market through the ATHENA randomized pivotal trial of the ANA Funnel Catheter in the United States and by building on published ANAIS study results that reported high proportions of successful reperfusion without severe device-related adverse events. Regulatory expansion and platform growth funnel into the same neurointerventional buyer base in Europe and, pending trial outcomes, the United States.
The funnel catheter design pairs aspiration power comparable to large-bore catheters with the flow arrest and flow reversal benefits normally associated with balloon guide catheters in a single working device. The self-expanding funnel is atraumatic to vessel walls and maintains a large clot receptacle at the thrombus interface during retrieval.
This combination is intended to improve clot capture, reduce distal embolization, and support reperfusion in fewer device passes, which is the main efficiency target in mechanical thrombectomy. The company also manufactures its devices in-house at a facility near Barcelona, keeping development, nitinol processing, and quality control under direct control.